IV delivery of VY1706, a CNS penetrant AAV gene therapy for AD, demonstrates compelling pharmacology and safety in a 3-month ...
Kopin Corporation (NASDAQ: KOPN), a leading provider of application-specific optical systems and high-performance microdisplays, including MicroLED displays, today announced a strategic collaboration ...
Check out the latest stories, videos, and podcasts from the week of Apr. 27, 2026. Though I’ve recommended that you avoid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results